Journal for ImmunoTherapy of Cancer (Nov 2023)
1041 Discovery of a potential first-in-class small molecule inhibitor of ADAR1 p150 which demonstrates strong anti-tumor efficacy in B16F10 syngeneic melanoma model
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)